NIDA SUPPLEMENTAL INFORMATION TO THE NIH CAREER DEVELOPMENT PROGRAMANNOUNCEMENTS (K AWARDS) NIH Guide, Volume 26, Number 5, February 14, 1997 P.T. 34 Keywords: Biomedical Research, Multidiscipl Clinical Medicine, General Grants Administration/Policy+ Drugs/Drug Abuse National Institute on Drug Abuse PURPOSE This clarification to NIDA Supplemental Information (published in the NIH Guide, Vol. 24, No. 32, September 1, 1995) to the National Institutes of Health (NIH) career development program announcements (K Awards) is intended to provide additional information for potential applicants on the unique aspects of National Institute on Drug Abuse (NIDA) career development programs. Two sections have been added -- renewal of K02 and eligibility requirements of the K01. The NIH program announcements addressed by this supplement are the following: o PA-95-049: Mentored Research Scientist Development Award (K01) o PA-95-050: Independent Scientist Award (K02) o PA-95-051: Senior Scientist Award (K05) o PA-95-053: Mentored Clinical Scientist Development Award (K08) o PA-95-054: Mentored Clinical Scientists Development Program Award (K12) The guidelines and procedures outlined in the NIH program announcements must be followed closely when an application is being prepared for submission to the NIDA. Particular attention should be paid to the purpose of each award mechanism, its eligibility requirements, and its review considerations. For example, the K12 program mechanism will accommodate the research career pathways of clinicians in fields related to NIDA's research mission. Under the K12 award, support will be provided to eligible institutions to develop or enhance research training opportunities for clinicians selected by the institution, who are training for careers as independent researchers in the drug abuse and addiction area of biomedical and behavioral research. The K12 mechanism is designed to foster the development of advanced clinical research skills through didactic training and the mentored research experience. Potential applicants should contact appropriate NIDA staff for further information. Supplemental Information for NIDA Applicants The RESEARCH OBJECTIVES section of each program announcement should be followed carefully during the preparation of an application. Note especially that differences exist among various NIH Institutes regarding allowable costs. The unique aspects of NIDA allowable costs, specifically in the categories of salary (all Ks) and research development support (K01, K08), are listed below. Salary The NIDA contribution to the Principal Investigator's salary is geared to the institutional base salary as follows: Institutional Base Salary NIDA Contribution o Up to $45,000 100% of institutional base o $45,001 to $60,000 $45,000 o $60,001 and over 75% of institutional base salary, Up to $75,000 Research Development Support (K01, K08) The NIDA allows for funds up to $50,000 per year for research related costs outlined in each program announcement. Renewals (K02) The Independent Scientist Award (K02) is renewable one time only. Eligibility Requirements (K01) A candidate for the Mentored Research Scientist Development Award (K01) may not concurrently apply for any other PHS award that duplicates the provisions of this award nor have another application pending award. INQUIRIES Consultation with NIDA staff is encouraged especially during the planning phase of the application. Below are the names of the NIDA staff who can provide further information: Timothy P. Condon, Ph.D. Office of Science Policy and Communications National Institute on Drug Abuse 5600 Fishers Lane, Room 10A-55 Rockville, MD 20857 Telephone: (301) 443-6072 FAX: (301) 443-6277 Email: TC52X@NIH.GOV Lucinda L. Miner, Ph.D. Office of Science Policy and Communications Telephone: (301) 443-6071 Email: CM171W@NIH.GOV Charles W. Sharp, Ph.D. Basic Research Parklawn Building, Room 10A-31 Telephone: (301) 443-lB87 FAX: (301) 594-6043 Email: CS107M@NIH.GOV Arthur Horton, Ed.D. Clinical and Services Research Parklawn Building, Room 10A-30 Telephone: (301) 443-4060 FAX: (301) 443-2317 Email: AH6lX@NIH.GOV Ann Blanken Epidemiology and Prevention Research Parklawn Building, Room 9A-55 Telephone: (301) 443-6S43 FAX: (301) 443-9847 Email: AB108V@NIH.GOV Jamie Biswas, Ph.D. Medications Development Parklawn Building, Room llA-55 Telephone: (301) 443-5280 (301) 443-2599 Email: JB168R@NIH.GOV .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |